Newly published AusVaxSafety surveillance data of more than 1,300 first doses of JYNNEOS® has revealed that 54% of vaccinees experienced no side effects in the first 7 days following vaccination. Of the vaccinees reporting symptoms, side effects were commonly mild and short lived and included local reactions, fatigue, headache and muscle/joint pain.
In order to inform further guidance around the use of JYNNEOS® in Australia, AusVaxSafety will continue to collect and publish this information, including side effects following dose 2.
To read the update in full, please click on the link below.
World-first real-time safety data for JYNNEOS monkeypox vaccine available from AusVaxSafety